understanding and working with new immunotherapeutic and targeted management models in advanced rcc
Published 4 years ago • 168 plays • Length 38:09Download video MP4
Download video MP3
Similar videos
-
1:37:34
nursing strategies for rcc: optimizing outcomes with novel targeted and immune-based therapies
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
1:16:25
rcc masterclass and clinical consult: novel immune and targeted therapies
-
1:03:29
rcc: current applications, controversies, and future use of immunotherapy and targeted agents
-
42:36
toxicity management in advanced renal cell carcinoma: immunotherapy insights
-
39:36
management of first line advanced rcc in era of immuno-oncology
-
28:07
management of locally advanced rcc (lnd, ivc, thrombus, adjuvant, neoadjuvant therapy)
-
1:26:54
novel therapeutic strategies to individualize patient care in rcc: expert-led clinical consults
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
1:05:38
watch drs. choueiri, mcdermott, and tannir, discuss the latest in rcc: https://bit.ly/3n3x59m
-
1:38:51
clinically meaningful outcomes among expanding treatment options in rcc
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
29:11
new data and clinical context: an update on renal cell carcinoma care
-
5:23
immunotherapy-based management of metastatic clear-cell and variant rcc: what can we achieve?
-
1:42:43
experts discuss the latest #rcc updates from #onscongress - https://bit.ly/3l3pazu
-
1:23:33
fine-tuning the wave of innovation in rcc
-
54:37
optimizing patient outcomes in rcc through safe use of immuno-oncology and targeted approaches